THE CLINICAL AND PATHOGENETIC FEATURES OF OBESITY-ASSOCIATED OSTEOARTHROSIS
https://doi.org/10.14412/1995-4484-2011-1457
Abstract
Objective: to assess the course of osteoarthrosis associated with obesity, by examining the secretion of hormones produced by adipose tissue, as well as that of proinflammatory cytokines.
Subjects and methods. Eighty-one patients aged 47 to 73 years, who had been diagnosed as having osteoarthrosis in accordance with the criteria developed by R. Altman, were examined. Anthropometric characteristics, the duration of the disease, the degree of functional fail- ure, and the levels of adipocytokines (adiponectin, interleukins (IL) 4 and 6) were estimated and X-ray study of the joints was conducted in all the patients. The impact of altered adipokine secretion on the course of osteoarthrosis and the degree of pain was evaluated.
Results and discussion. The elevated level of proinflammatory interleukin (IL-6) was associated with severer X-ray changes, higher func- tional failure, the presence of synovitis, and evident pain syndrome. At the same time, IL-4 and adiponectin were decreased in severe osteoarthrosis. Thus, the change in the level of the above adipokines is associated with the poor course of osteoarthrosis.
References
1. <div><p>Cooper C. Epidemiology of osteoarthritis. In: Klippel J.H., Dieppe P.A., eds. Rheumatology. 2nd ed. London: Mosby, 1998: 1-20</p><p>Вялков А.И., Гусев Е.И., Зборовский А.Б., Насонова В.А. Основные задачи международной декады (The bone and joint decade 2000-2010) в совершенствовании борьбы с наиболее распространенными заболеваниями опорно-двигательного аппарата в России. Науч-практич ревматол 2001;2:4-8.</p><p>Чазова И.Е., Мычка В.Б. Профилактика, диагностика и лечение метаболического синдрома. М., 2005; 4-5.</p><p>Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-56.</p><p>Delerive P., Gervois P., Fruchart J.C., Staels B. Induction of 1kВа expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferatoractivated receptor-а activators. J Biol Chem 2000;275:36703-7.</p><p>Walker-Bone K., Javaid K., Arden N., Cooper C. Medical management of osteoarthritis: Clinical review. BMJ 2000;321:936-40.</p><p>Kern P.A., Ranganathan S., Li C. et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280: E745-E751.</p><p>Stone K.R., Stoller D., De Carli A. et al. The frequency of Bakers cysts associated with medial tears. Am J Sports Med 1996;24(5):670-1.</p><p>Плохинский Н.А. Биометрия. Новосибирск, 1961; 364 с</p><p>Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of health care. Ann Rheum Dis 2001;60:91-7.</p><p>Garnero P., Delmas P.D. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003;15(5):641-6.</p><p>Kumar A., Takada Y., Boriek A.M., Aggarwal B.B. Nuclear factor-κB: its role in health and disease. J Mol Med 2004;82:434-48.</p><p>Воронкова Н.Б., Хрусталев О.А. Влияние артериальной гипертензии и абдоминального ожирения на течение и клинические проявления деформирующего остеоартроза коленных суставов у женщин. Рос кардиол журн 2005;3:28-32.</p></div><br />
Review
For citations:
Kopylova D.A., Ostapenko V.A. THE CLINICAL AND PATHOGENETIC FEATURES OF OBESITY-ASSOCIATED OSTEOARTHROSIS. Rheumatology Science and Practice. 2011;49(5):28-31. (In Russ.) https://doi.org/10.14412/1995-4484-2011-1457
Views:
966
Email this article 